NEW AMINOTHIAZOLES AS FBPASE INHIBITORS FOR DIABETES
申请人:Hebeisen Paul
公开号:US20090143448A1
公开(公告)日:2009-06-04
Compounds of formula (I)
as well as pharmaceutically acceptable salts and esters thereof, wherein R
1
to R
3
have the significance given in claim
1
and which can be used in the form of pharmaceutical compositions.
NEW PYRIDINES AS FBPASE INHIBITORS FOR TREATMENT OF DIABETES
申请人:Haap Wolfgang
公开号:US20090143439A1
公开(公告)日:2009-06-04
Compounds of formula (I)
as well as pharmaceutically acceptable salts and esters thereof wherein the residues have the significance given in claim
1
and which can be used in the form of pharmaceutical compositions.
Novel 2-sulfamoylbenzo[b]thiophenes and derivatives thereof are shown to be useful for the treatment of elevated intraocular pressure in compositions including ophthalmic drops and inserts.